Neoadjuvant nivolumab and chemotherapy in early estrogen receptor-positive breast cancer: a randomized phase 3 trial

unknow

★ 5.0 · 55 reads

Request Code
ZLIB.IO18490946
Published
2022
Pages
1
Language
Unknown